142 related articles for article (PubMed ID: 34712577)
21. [Functional difference of malate-aspartate shuttle system in liver between plateau zokor (Myospalax baileyi) and plateau pika (Ochotona curzoniae)].
Zhu RJ; Rao XF; Wei DB; Wang DW; Wei L; Sun SZ
Sheng Li Xue Bao; 2012 Apr; 64(2):177-86. PubMed ID: 22513468
[TBL] [Abstract][Full Text] [Related]
22. Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.
Sklirou E; Alodaib AN; Dobrowolski SF; Mohsen AA; Vockley J
Front Genet; 2020; 11():598760. PubMed ID: 33584796
[TBL] [Abstract][Full Text] [Related]
23. ARALAR/AGC1 deficiency, a neurodevelopmental disorder with severe impairment of neuronal mitochondrial respiration, does not produce a primary increase in brain lactate.
Juaristi I; García-Martín ML; Rodrigues TB; Satrústegui J; Llorente-Folch I; Pardo B
J Neurochem; 2017 Jul; 142(1):132-139. PubMed ID: 28429368
[TBL] [Abstract][Full Text] [Related]
24. Effects of L-malate on physical stamina and activities of enzymes related to the malate-aspartate shuttle in liver of mice.
Wu JL; Wu QP; Huang JM; Chen R; Cai M; Tan JB
Physiol Res; 2007; 56(2):213-220. PubMed ID: 16555951
[TBL] [Abstract][Full Text] [Related]
25. Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy.
Hadera MG; Smeland OB; McDonald TS; Tan KN; Sonnewald U; Borges K
J Neurochem; 2014 Apr; 129(1):107-19. PubMed ID: 24236946
[TBL] [Abstract][Full Text] [Related]
26. Personalized medicine approach confirms a milder case of ABAT deficiency.
Besse A; Petersen AK; Hunter JV; Appadurai V; Lalani SR; Bonnen PE
Mol Brain; 2016 Dec; 9(1):93. PubMed ID: 27903293
[TBL] [Abstract][Full Text] [Related]
27. [Molybdenum cofactor deficiency type B manifested as Leigh-like syndrome: a case report and literature review].
Tian XJ; Li X; Fang F; Liu ZM; Wu WJ; Liu K; Sun SZ
Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):119-124. PubMed ID: 33548958
[No Abstract] [Full Text] [Related]
28. Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice.
Park MJ; Aja S; Li Q; Degano AL; Penati J; Zhuo J; Roe CR; Ronnett GV
PLoS One; 2014; 9(10):e109527. PubMed ID: 25299635
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Genetic Characteristics of Mitochondrial Encephalopathy Due to
Hu C; Xu Q; Shen J; Wang Y
Front Neurol; 2021; 12():633397. PubMed ID: 33613441
[No Abstract] [Full Text] [Related]
30. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
[TBL] [Abstract][Full Text] [Related]
31. Anaplerotic Therapy Using Triheptanoin in Two Brothers Suffering from Aconitase 2 Deficiency.
Penkl M; Mayr JA; Feichtinger RG; Reilmann R; Debus O; Fobker M; Penkl A; Reunert J; Rust S; Marquardt T
Metabolites; 2024 Apr; 14(4):. PubMed ID: 38668366
[TBL] [Abstract][Full Text] [Related]
32. Triheptanoin alters [U-
McDonald T; Hodson MP; Bederman I; Puchowicz M; Borges K
J Cereb Blood Flow Metab; 2020 Mar; 40(3):678-691. PubMed ID: 30890077
[TBL] [Abstract][Full Text] [Related]
33. No effect of triheptanoin on exercise performance in McArdle disease.
Madsen KL; Laforêt P; Buch AE; Stemmerik MG; Ottolenghi C; Hatem SN; Raaschou-Pedersen DT; Poulsen NS; Atencio M; Luton MP; Ceccaldi A; Haller RG; Quinlivan R; Mochel F; Vissing J
Ann Clin Transl Neurol; 2019 Oct; 6(10):1949-1960. PubMed ID: 31520525
[TBL] [Abstract][Full Text] [Related]
34. Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin.
Breen C; White FJ; Scott CA; Heptinstall L; Walter JH; Jones SA; Morris AA
Eur J Pediatr; 2014 Mar; 173(3):361-6. PubMed ID: 24114256
[TBL] [Abstract][Full Text] [Related]
35. HIBCH deficiency in a patient with phenotypic characteristics of mitochondrial disorders.
Reuter MS; Sass JO; Leis T; Köhler J; Mayr JA; Feichtinger RG; Rauh M; Schanze I; Bähr L; Trollmann R; Uebe S; Ekici AB; Reis A
Am J Med Genet A; 2014 Dec; 164A(12):3162-9. PubMed ID: 25251209
[TBL] [Abstract][Full Text] [Related]
36. Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis.
Tefera TW; Wong Y; Barkl-Luke ME; Ngo ST; Thomas NK; McDonald TS; Borges K
PLoS One; 2016; 11(8):e0161816. PubMed ID: 27564703
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
[TBL] [Abstract][Full Text] [Related]
38. Regulation of mitochondrial and cytosolic malic enzymes from cultured rat brain astrocytes.
McKenna MC; Tildon JT; Stevenson JH; Huang X; Kingwell KG
Neurochem Res; 1995 Dec; 20(12):1491-501. PubMed ID: 8789613
[TBL] [Abstract][Full Text] [Related]
39. Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency.
McMillan HJ; Worthylake T; Schwartzentruber J; Gottlieb CC; Lawrence SE; Mackenzie A; Beaulieu CL; Mooyer PA; ; Wanders RJ; Majewski J; Bulman DE; Geraghty MT; Ferdinandusse S; Boycott KM
Orphanet J Rare Dis; 2012 Nov; 7():90. PubMed ID: 23181892
[TBL] [Abstract][Full Text] [Related]
40. The ketogenic diet compensates for AGC1 deficiency and improves myelination.
Dahlin M; Martin DA; Hedlund Z; Jonsson M; von Döbeln U; Wedell A
Epilepsia; 2015 Nov; 56(11):e176-81. PubMed ID: 26401995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
